Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 187,213
- Value
- $17.0M
- % of portfolio
- 0.7%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 187,213 | $17.0M | 0.7% | −2,400−1.3% | Reduced | Holders |
| Q1 2026 | 189,613 | $19.5M | 1.0% | +2,448+1.3% | Added | Holders |
| Q4 2025 | 187,165 | $23.4M | 1.2% | −438−0.2% | Reduced | Holders |
| Q3 2025 | 187,603 | $25.1M | 1.3% | +5,525+3.0% | Added | Holders |
| Q2 2025 | 182,078 | $24.8M | 1.4% | +4,882+2.8% | Added | Holders |
| Q1 2025 | 177,196 | $23.5M | 1.5% | +4,798+2.8% | Added | Holders |
| Q4 2024 | 172,398 | $19.5M | 1.3% | +1,748+1.0% | Added | Holders |
| Q3 2024 | 170,650 | $19.5M | 1.3% | +4,253+2.6% | Added | Holders |
| Q2 2024 | 166,397 | $17.3M | 1.2% | +18,283+12.3% | Added | Holders |
| Q1 2024 | 148,114 | $16.8M | 1.3% | −42,216−22.2% | Reduced | Holders |
| Q4 2023 | 190,330 | $20.9M | 1.4% | +6,066+3.3% | Added | Holders |
| Q3 2023 | 184,264 | $17.8M | 1.3% | +5,836+3.3% | Added | Holders |
| Q2 2023 | 178,428 | $19.5M | 1.4% | −390.0% | Reduced | Holders |
| Q1 2023 | 178,467 | $18.1M | 1.4% | +4,309+2.5% | Added | Holders |
| Q4 2022 | 174,158 | $19.1M | 1.6% | −308−0.2% | Reduced | Holders |
| Q3 2022 | 174,466 | $16.9M | 1.6% | +688+0.4% | Added | Holders |
| Q2 2022 | 173,778 | $18.9M | 1.6% | +6,354+3.8% | Added | Holders |
| Q1 2022 | 167,424 | $19.8M | 1.5% | +2,234+1.4% | Added | Holders |
| Q4 2021 | 165,190 | $23.2M | 1.6% | +94+0.1% | Added | Holders |
| Q3 2021 | 165,096 | $19.5M | 1.5% | +2,942+1.8% | Added | Holders |
| Q2 2021 | 162,154 | $18.8M | 1.5% | +5,529+3.5% | Added | Holders |
| Q1 2021 | 156,625 | $18.8M | 1.7% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.